Published in Am J Med Genet on September 25, 1995
The Smith-Lemli-Opitz syndrome. J Med Genet (2000) 3.05
Disorders of cholesterol biosynthesis. Arch Dis Child (1998) 0.93
Smith-Lemli-Opitz syndrome: a treatable inherited error of metabolism causing mental retardation. CMAJ (1999) 0.90
Adverse pregnancy outcomes after abnormal first-trimester screening for aneuploidy. Clin Lab Med (2010) 0.82
Diagnosis of inherited disorders of liver metabolism. J Inherit Metab Dis (2003) 0.78
Delta-NT or NT MoM: which is the most appropriate method for calculating accurate patient-specific risks for trisomy 21 in the first trimester? Ultrasound Obstet Gynecol (2003) 3.75
Quantification of cervical elastography: a reproducibility study. Ultrasound Obstet Gynecol (2012) 3.15
Ultrasound-guided sampling of umbilical cord and placental blood to assess fetal wellbeing. Lancet (1986) 2.72
The management of severe rhesus isoimmunization by fetoscopic intravascular transfusions. Am J Obstet Gynecol (1984) 2.28
Nasal bone hypoplasia in trisomy 21 at 15-22 weeks' gestation. Ultrasound Obstet Gynecol (2003) 2.20
Effectiveness of progestogens to improve perinatal outcome in twin pregnancies: an individual participant data meta-analysis. BJOG (2014) 2.20
Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis. Ultrasound Obstet Gynecol (2013) 2.16
Early ultrasound diagnosis and follow-up of molar pregnancies. Ultrasound Obstet Gynecol (1997) 2.10
Down's syndrome screening in the UK. Lancet (1996) 2.02
Fetal right ventricular contraction and relaxation times at 11-13 weeks' gestation on speckle tracking imaging. Ultrasound Obstet Gynecol (2014) 2.00
Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester. Ultrasound Obstet Gynecol (2001) 2.00
Longitudinal changes in maternal corin and mid-regional proatrial natriuretic peptide in women at risk of pre-eclampsia. Ultrasound Obstet Gynecol (2014) 1.99
Pyridoxal 5'-phosphate may be curative in early-onset epileptic encephalopathy. J Inherit Metab Dis (2006) 1.98
Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol (2015) 1.96
Prenatal diagnosis of a red-cell enzymopathy: triose phosphate isomerase deficiency. Lancet (1989) 1.94
Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation. Br J Obstet Gynaecol (1995) 1.93
Cervical length at 23 weeks of gestation: prediction of spontaneous preterm delivery. Ultrasound Obstet Gynecol (1998) 1.90
International, collaborative experience of 1789 patients having multifetal pregnancy reduction: a plateauing of risks and outcomes. J Soc Gynecol Investig (1996) 1.87
Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis method. Ultrasound Obstet Gynecol (2012) 1.83
Are all infants of diabetic mothers "macrosomic"? BMJ (1988) 1.81
Evolution of maternofetal transport of immunoglobulins during human pregnancy. Am J Reprod Immunol (1996) 1.79
A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol (1999) 1.79
Maturation of the secretion of thyroid hormone and thyroid-stimulating hormone in the fetus. N Engl J Med (1991) 1.78
First-trimester determination of fetal gender by ultrasound. Ultrasound Obstet Gynecol (1999) 1.71
First-trimester transabdominal fetal echocardiography. Lancet (1998) 1.70
Hypertriglyceridemia and hypoxemia in small-for-gestational-age fetuses. Am J Obstet Gynecol (1990) 1.69
Measurement of human fetoplacental blood volume in erythroblastosis fetalis. Am J Obstet Gynecol (1987) 1.68
Alström syndrome. Report of 22 cases and literature review. Ophthalmology (1998) 1.67
Color Doppler imaging of the uterine artery in pregnancy: normal ranges of impedance to blood flow, mean velocity and volume of flow. Ultrasound Obstet Gynecol (1992) 1.63
Maternal age and adverse pregnancy outcome: a cohort study. Ultrasound Obstet Gynecol (2013) 1.61
Prenatal asphyxia, hyperlacticaemia, hypoglycaemia, and erythroblastosis in growth retarded fetuses. Br Med J (Clin Res Ed) (1987) 1.60
Mutations in the gene encoding peroxisomal alpha-methylacyl-CoA racemase cause adult-onset sensory motor neuropathy. Nat Genet (2000) 1.58
Nodular transformation of the liver associated with portal and pulmonary arterial hypertension. Gastroenterology (1993) 1.57
Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation. Ultrasound Obstet Gynecol (2001) 1.56
Prenatal diagnosis and outcome of echogenic fetal lung lesions. Ultrasound Obstet Gynecol (2008) 1.56
The anatomy of the umbilical, portal and hepatic venous systems in the human fetus at 14-19 weeks of gestation. Ultrasound Obstet Gynecol (2001) 1.55
Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus blood flow at 10-14 weeks. Ultrasound Obstet Gynecol (1999) 1.55
Labor: an immunologically beneficial process for the neonate. Am J Obstet Gynecol (1994) 1.54
Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation. Ultrasound Obstet Gynecol (2003) 1.54
Screening for trisomies 21, 18 and 13 by cell-free DNA analysis of maternal blood at 10-11 weeks' gestation and the combined test at 11-13 weeks. Ultrasound Obstet Gynecol (2014) 1.53
Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study. BMJ (1999) 1.50
Relationship between fetal acidemia at cordocentesis and subsequent neurodevelopment. Ultrasound Obstet Gynecol (1992) 1.50
Improvement in outcomes of multifetal pregnancy reduction with increased experience. Am J Obstet Gynecol (2001) 1.50
Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol (2008) 1.49
Inter-arm blood pressure differences in pregnant women. BJOG (2008) 1.47
Fetal immunological and haematological changes in intrauterine infection. Br J Obstet Gynaecol (1994) 1.47
Trichorionic triplet pregnancies at 10-14 weeks: outcome after embryo reduction compared to expectant management. J Matern Fetal Neonatal Med (2002) 1.46
Fetal biometry at 4300 m compared to sea level in Peru. Ultrasound Obstet Gynecol (2000) 1.45
Hematologic profile of neonates with growth restriction is associated with rate and degree of prenatal Doppler deterioration. Ultrasound Obstet Gynecol (2012) 1.43
Transabdominal versus transcervical and transvaginal multifetal pregnancy reduction: international collaborative experience of more than one thousand cases. Am J Obstet Gynecol (1994) 1.43
Have Liley charts outlived their usefulness? Am J Obstet Gynecol (1986) 1.42
Ventilatory requirements for respiratory distress syndrome in small-for-gestational-age infants. Eur J Pediatr (1992) 1.41
Doppler study of the fetal circulation during long-term maternal hyperoxygenation for severe early onset intrauterine growth retardation. Ultrasound Obstet Gynecol (1991) 1.41
First-trimester markers of aneuploidy in women positive for HIV. BJOG (2010) 1.41
Increased nuchal translucency thickness at 10-14 weeks of gestation as a predictor of severe twin-to-twin transfusion syndrome. Ultrasound Obstet Gynecol (1997) 1.41
Middle cerebral artery flow velocity waveforms in fetal hypoxaemia. Br J Obstet Gynaecol (1990) 1.40
Choroid plexus cysts and chromosomal defects. Br J Radiol (1990) 1.40
Predicting the severity of rhesus alloimmunization: monocyte-mediated chemiluminescence versus maternal anti-D antibody estimation. Br J Haematol (1994) 1.40
The role of trophoblast dysfunction in the aetiology of miscarriage. Br J Obstet Gynaecol (1993) 1.40
Perinatal features associated with placental mesenchymal dysplasia. Placenta (1997) 1.40
The mitral gap at 11 + 0 to 13 + 6 weeks: marker of trisomy 21 or artifact? Ultrasound Obstet Gynecol (2007) 1.39
Morbidity in infants with antenatally-diagnosed anterior abdominal wall defects. Pediatr Surg Int (2000) 1.39
Early diagnosis of chronic fetal hypoxia in a diabetic pregnancy. Br Med J (Clin Res Ed) (1988) 1.39
Fetal middle cerebral artery and umbilical artery pulsatility index: effects of maternal characteristics and medical history. Ultrasound Obstet Gynecol (2015) 1.39
Normal venous circulation of the gastroesophageal junction. A route to understanding varices. Gastroenterology (1987) 1.39
Clinical significance of first-trimester chorionic bumps: a matched case-control study. Ultrasound Obstet Gynecol (2013) 1.38
Uterine artery Doppler at 11-14 weeks of gestation in chromosomally abnormal fetuses. Ultrasound Obstet Gynecol (2001) 1.38
Idiopathic rhabdomyolysis. J R Soc Med (1996) 1.38
Longitudinal changes in maternal hemodynamics in a population at risk for pre-eclampsia. Ultrasound Obstet Gynecol (2014) 1.38
Umbilical and fetal middle cerebral artery Doppler at 30-34 weeks' gestation in the prediction of adverse perinatal outcome. Ultrasound Obstet Gynecol (2015) 1.38
Longitudinal changes in maternal soluble endoglin and angiopoietin-2 in women at risk for pre-eclampsia. Ultrasound Obstet Gynecol (2014) 1.37
Fetal karyotyping in twin pregnancies: selection of technique by measurement of fetal nuchal translucency. Br J Obstet Gynaecol (1996) 1.37
Ultrasound screening for anencephaly at 10-14 weeks of gestation. Ultrasound Obstet Gynecol (1997) 1.37
Development of a training model for ultrasound-guided invasive procedures in fetal medicine. Ultrasound Obstet Gynecol (1995) 1.36
Color Doppler study of the venous circulation in the fetal brain and hemodynamic study of the cerebral transverse sinus. Ultrasound Obstet Gynecol (1999) 1.36
Cervical length and funneling at 23 weeks of gestation in the prediction of spontaneous early preterm delivery. Ultrasound Obstet Gynecol (2001) 1.35
Analysis of cell-free DNA in maternal blood in screening for aneuploidies: meta-analysis. Fetal Diagn Ther (2014) 1.33
Limitations of using first-trimester nuchal translucency measurement in routine screening for major congenital heart defects. Ultrasound Obstet Gynecol (2001) 1.33
Ultrasound screening for spina bifida: cranial and cerebellar signs. Lancet (1986) 1.32
Outcome of medium chain acyl-CoA dehydrogenase deficiency after diagnosis. Arch Dis Child (1999) 1.32
Expectant management of missed miscarriage. Br J Obstet Gynaecol (1998) 1.32
Familial giant cell hepatitis associated with synthesis of 3 beta, 7 alpha-dihydroxy-and 3 beta,7 alpha, 12 alpha-trihydroxy-5-cholenoic acids. J Clin Invest (1987) 1.32
Intrapartum sonography to determine fetal head position. J Matern Fetal Neonatal Med (2002) 1.29
Effect of gestational age on fetal and intervillous blood gas and acid-base values in human pregnancy. Fetal Ther (1986) 1.28
Hereditary tyrosinemia type I: a new clinical classification with difference in prognosis on dietary treatment. Hepatology (1994) 1.28
Cordocentesis for the diagnosis and treatment of human fetal parvovirus infection. Obstet Gynecol (1990) 1.27
Blood glucose and oxygen tension levels in small-for-gestational-age fetuses. Am J Obstet Gynecol (1989) 1.27
Plasma insulin in appropriate- and small-for-gestational-age fetuses. Am J Obstet Gynecol (1989) 1.27
Second-trimester uterine artery Doppler screening in unselected populations: a review. J Matern Fetal Neonatal Med (2002) 1.26
Screening of newborn infants for cholestatic hepatobiliary disease with tandem mass spectrometry. BMJ (1999) 1.26
Prevention of preterm delivery in twin gestations (PREDICT): a multicenter, randomized, placebo-controlled trial on the effect of vaginal micronized progesterone. Ultrasound Obstet Gynecol (2011) 1.25
Maternal age- and gestation-specific risk for trisomy 21. Ultrasound Obstet Gynecol (1999) 1.25
3-Oxo-delta 4 bile acids in liver disease. Lancet (1988) 1.24
Mutations in SRD5B1 (AKR1D1), the gene encoding delta(4)-3-oxosteroid 5beta-reductase, in hepatitis and liver failure in infancy. Gut (2003) 1.24
One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks' gestation. Obstet Gynecol (2000) 1.24
Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation. Ultrasound Obstet Gynecol (1998) 1.24
The prevalence of non-viable pregnancy at 10-13 weeks of gestation. Ultrasound Obstet Gynecol (1996) 1.22
Maternal oxygen therapy for intrauterine growth retardation. Lancet (1987) 1.22